Help Massachusetts Get Important Lyme Disease Treatment Senate Bill Passed

The state of Massachusetts, including Cape Cod and the islands, are severely infested with Lyme disease and a rampant tick population. The state has struggled severely, with doctors hands strapped and unable to treat patients properly with prompt and aggressive antibiotic therapy to eliminate a new acute infection of the illness, as well as address the long-term ramifications of longer chronic infections.

Thousands of people in Massachusetts and throughout the world are struggling with this quirky bacteria and its ability to move into multiple systems of the body, causing chronic conditions, many of them of an autoimmune-style and nervous system nature.

Please read this message below about an important bill in process in Massachusetts that would enable doctors to more properly treat individuals without insurance companies controlling them. Thank you Trish McCleary, Enid Haller, and other members of the Lyme disease coalition in Massachusetts for forging ahead with this work. Other states need to replicate your efforts.

The Massachusetts Lyme Coalition says, “This time period is crucial and we need you to reach out to your family members and friends and ask that they contact their legislator and ask him/her to sign on as a co-sponsor to H.D.469.  Reps need to hear from their constituents- that is you!  So please reach out to your Representative today and ask them to sign on to H.D. 469.”

Friends please pass this blog along.

Sincerely,

Katina Makris, CCH, CIH

HOUSE DOCKET, NO. 469 FILED ON: 1/13/2015

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

David Paul Linsky

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act relative to Lyme disease treatment coverage.

_______________

PETITION OF:

 

Name: District/Address:
David Paul Linsky 5th Middlesex

 

The Commonwealth of Massachusetts

_______________

In the One Hundred and Eighty-Ninth General Court
(2015-2016)

_______________

An Act relative to Lyme disease treatment coverage.

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:

SECTION 1. Chapter 175 of the General Laws is hereby amended by inserting after

section 47DD, the following section:

Section 47EE.

(A) For the purposes of this Section, the terms “Lyme disease” and “long-term antibiotic

therapy” are given the same definition as provided in M.G.L. Chapter 112, Section 12DD.

(B) Any policy, contract, agreement, plan or certificate of insurance issued, delivered or renewed within the commonwealth that provides medical expense coverage shall provide coverage for long-term antibiotic therapy of Lyme disease when determined to be medically necessary and ordered by a licensed physician after making a thorough evaluation of the patient’s symptoms, diagnostic test results, or response to treatment. Long-term antibiotic therapy otherwise eligible for benefits pursuant to this section shall not be denied solely because such treatment may be characterized as unproven, experimental, or investigational in nature.

SECTION 2. Chapter 176A of the General Laws is hereby amended by inserting after

section 8FF the following section:-

Section 8GG. Any contract between a subscriber and the corporation under an individual or group hospital service plan which is delivered, issued or renewed within the commonwealth shall provide coverage for long-term antibiotic therapy of Lyme disease when determined to be medically necessary and ordered by a licensed physician after making a thorough evaluation of the patient’s symptoms, diagnostic test results or response to treatment.

Treatment otherwise eligible for benefits pursuant to this section shall not be denied solely because such treatment may be characterized as unproven, experimental, or investigational in nature.

SECTION 4. Chapter 176B of the General Laws is hereby amended by inserting after section 4FF, the following section:-

Section 4GG. Any subscription certificate under an individual or group medical service agreement delivered, issued, or renewed within the commonwealth shall provide coverage for

long-term antibiotic therapy of Lyme disease when determined to be medically necessary and ordered by a licensed physician after making a thorough evaluation of the patient’s symptoms, diagnostic test results or response to treatment. Treatment otherwise eligible for benefits pursuant to this section shall not be denied solely because such treatment may be characterized as unproven, experimental, or investigational in nature.

SECTION 5. Chapter 176G of the General Laws is hereby amended by inserting after

section 4X the following section:-

Section 4Y. Any individual or group health maintenance contract shall provide coverage

for long-term antibiotic therapy of Lyme disease when determined to be medically necessary and ordered by a licensed physician after making a thorough evaluation of the patient’s symptoms, diagnostic test results or response to treatment. Treatment otherwise eligible for benefits pursuant to this section shall not be denied solely because such treatment may be characterized as unproven, experimental, or investigational in nature.